Donald Trump signed an executive order creating a women's health division at the National Institutes of Health. First Lady Melania Trump has promoted the action as a major step for women's health in the United States.
4:29 PMAl Jazeera18 stories from 8 sources
Women’s health gets a new federal structure, but impact awaits funding
Day’s Recap
Supporting Articles
Researchers identified a rare mutation that appears to protect some people with a high-risk Alzheimer’s gene from harmful protein buildup and cognitive decline. The discovery may reveal a biological defense that future therapies could reproduce.
8:57 AMScienceDaily
Doctors who volunteered in Gaza described working in hospitals damaged and overwhelmed during Israel’s war in the territory. Their accounts focus on the destruction of medical facilities and the conditions facing healthcare workers and patients.
9:36 AMAl Jazeera
A STAT investigation found that several nonprofits serving as arbitrators under the No Surprises Act are collecting large sums while deciding payment disputes. The program was designed to protect patients from surprise medical bills, but the arbitrators' financial incentives and broad discretion are under scrutiny.
4:30 AMStat News
A Gilead Sciences oral treatment eliminated symptoms in patients with a form of inflammatory bowel disease in a mid-stage study. The results offer an early clinical test of the drug's potential as a new treatment option.
4:35 AMStat News4:29 PMAl Jazeera
Trump signs order launching women’s health division at NIH, White House
Summary
Donald Trump signed an executive order creating a women's health division at the National Institutes of Health. First Lady Melania Trump has promoted the action as a major step for women's health in the United States.
The order creates a new federal structure intended to focus NIH research and policy attention
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The initiative could redirect federal research resources toward conditions and evidence gaps that have historically received less attention in women's health.
3 stories · 3 sources
8:57 AMScienceDaily
Why some people escape Alzheimer’s despite carrying a high-risk gene
Summary
Researchers identified a rare mutation that appears to protect some people with a high-risk Alzheimer’s gene from harmful protein buildup and cognitive decline. The discovery may reveal a biological defense that future therapies could reproduce.
The decisive finding is that genetic risk does not act alone: a protective mutation can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A natural protective pathway could provide a new target for Alzheimer’s prevention before irreversible damage occurs.
9:36 AMAl Jazeera
Doctors describe hospitals shattered by Israel’s genocide in Gaza
Summary
Doctors who volunteered in Gaza described working in hospitals damaged and overwhelmed during Israel’s war in the territory. Their accounts focus on the destruction of medical facilities and the conditions facing healthcare workers and patients.
The testimony points to the collapse of hospital capacity as a direct consequence of the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
When hospitals lose buildings, staff, and supplies, the damage extends beyond immediate casualties to the territory’s ability to treat illness and injury.
4:30 AMStat News
STAT+: How the No Surprises Act’s nonprofit arbitrators are operating like ‘mini gods’ and getting rich doing it
Summary
A STAT investigation found that several nonprofits serving as arbitrators under the No Surprises Act are collecting large sums while deciding payment disputes. The program was designed to protect patients from surprise medical bills, but the arbitrators' financial incentives and broad discretion are under scrutiny.
The arbitration system may have shifted leverage from surprise-billed patients to intermediaries whose decisions can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A safeguard against surprise bills can still inflate healthcare costs if the dispute-resolution system lacks effective oversight.
4:35 AMStat News
STAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
Summary
A Gilead Sciences oral treatment eliminated symptoms in patients with a form of inflammatory bowel disease in a mid-stage study. The results offer an early clinical test of the drug's potential as a new treatment option.
The study shifts Gilead's drug from a development concept toward a potentially viable therapy, but
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Positive mid-stage data could expand treatment choices for patients with difficult-to-manage bowel disease.
Other Developments
A curated list of other prominent stories from this day.
Synthetic opioids such as fentanyl have become more potent and widely available, reshaping the drug landscape. A US church is working on the frontline of the response to the drug known as tranq.
8:02 PMBBC
Deep-vein thrombosis and pulmonary embolism can affect elite athletes, and research suggests treatment may keep them out of competition for more than six months. The risk is not limited to older or less active people.
7:11 AMMarketWatch
Researchers found molecular abnormalities in the taste buds of people who continued to experience taste loss more than a year after COVID-19. These changes appear to weaken signals for sweet, bitter, and savory flavors.
8:03 AMScienceDaily
New research links walking at least 3,000 steps a day with less tau buildup and roughly half the cognitive and functional decline in people showing early signs of Alzheimer’s. The strongest association appeared among those taking 5,000 to 7,500 steps daily, below the commonly promoted 10,000-step target.
7:23 AMScienceDaily
New York City has launched a tool to help residents find mental health and addiction services. It addresses a common barrier: many people who want care do not know where to begin.
6:30 AMGothamist
In mice, researchers restored more than two hours of daily sleep by temporarily removing overactive immune cells in the brain. The result suggests that Alzheimer’s-related sleep disruption can improve without removing the disease’s characteristic plaques.
5:19 AMScienceDaily
Internal emails show that the American Association of Immunologists is divided over California Proposition 38, which would direct $8.4 billion in taxpayer funding to immunology. The dispute exposes disagreement within the field over a major public investment.
4:30 AMStat News
Physicians and former Republican lawmakers argue that the resurgence of measles is becoming a political liability for Republicans who remain silent on vaccination. They contend that vaccine positions could alienate voters who otherwise support the party.
4:30 AMStat News
In a personal essay, Torie Bosch argues that assisted suicide should be considered for some people with severe mental illness, drawing on her mother's suicide. The essay challenges the assumption that medical aid in dying should be limited to physical illnesses.
4:30 AMStat News
Isomorphic Labs is trying to turn its technology into a platform for discovering new medicines. Its central challenge is proving that the technology can produce effective drugs, not merely promising computational predictions.
4:30 AMStat News
Many insured adults still avoid needed care because medical bills can trigger credit checks or become unaffordable. The article argues that employers track premiums but rarely measure the cost of delayed or forgone treatment.
4:00 AMPYMNTS8:02 PMBBC
US church on front line of battle against drug known as 'tranq'
Summary
Synthetic opioids such as fentanyl have become more potent and widely available, reshaping the drug landscape. A US church is working on the frontline of the response to the drug known as tranq.
The spread of tranq shows how the illicit drug supply is creating needs that conventional
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Community institutions are becoming essential partners as a more dangerous and unpredictable drug supply outpaces formal services.
7:11 AMMarketWatch
Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.
Summary
Deep-vein thrombosis and pulmonary embolism can affect elite athletes, and research suggests treatment may keep them out of competition for more than six months. The risk is not limited to older or less active people.
A blood clot can impose a long recovery even when the patient is young, highly
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Blood clots can disrupt elite careers and require prolonged risk management, not just short-term treatment.
8:03 AMScienceDaily
Scientists discover why some people still can’t taste food after COVID-19
Summary
Researchers found molecular abnormalities in the taste buds of people who continued to experience taste loss more than a year after COVID-19. These changes appear to weaken signals for sweet, bitter, and savory flavors.
The findings move persistent post-COVID taste loss from a largely unexplained symptom toward a specific
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Identifying damaged taste signaling may help clinicians distinguish persistent biological injury from temporary sensory disruption.
7:23 AMScienceDaily
Just 3,000 steps a day may help slow Alzheimer's, scientists find
Summary
New research links walking at least 3,000 steps a day with less tau buildup and roughly half the cognitive and functional decline in people showing early signs of Alzheimer’s. The strongest association appeared among those taking 5,000 to 7,500 steps daily, below the commonly promoted 10,000-step target.
The key shift is that modest activity may correlate with slower disease progression, even after
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A lower daily step target could make brain-health advice more practical for older adults at risk.
6:30 AMGothamist
Need help with mental health or addiction services? NYC has a new tool.
Summary
New York City has launched a tool to help residents find mental health and addiction services. It addresses a common barrier: many people who want care do not know where to begin.
The city is trying to reduce the first-step problem in behavioral health by making service
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Easier navigation can convert unmet demand for behavioral health care into actual treatment.
5:19 AMScienceDaily
"Mind-blowing" Alzheimer’s breakthrough: Two hours of sleep restored without clearing brain plaques
Summary
In mice, researchers restored more than two hours of daily sleep by temporarily removing overactive immune cells in the brain. The result suggests that Alzheimer’s-related sleep disruption can improve without removing the disease’s characteristic plaques.
The important shift is therapeutic: sleep loss may be driven partly by inflammatory brain cells,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A treatment aimed at brain inflammation could address a debilitating Alzheimer’s symptom without requiring plaque clearance.
4:30 AMStat News
STAT+: Top immunology association divided over $8.4-billion California ballot measure to fund the field, emails show
Summary
Internal emails show that the American Association of Immunologists is divided over California Proposition 38, which would direct $8.4 billion in taxpayer funding to immunology. The dispute exposes disagreement within the field over a major public investment.
The split means the measure faces not only a political test but also a credibility
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A large public research program can become harder to defend when its intended beneficiaries cannot agree on it.
4:30 AMStat News
Opinion: Measles is back — and becoming a midterm liability for Republicans
Summary
Physicians and former Republican lawmakers argue that the resurgence of measles is becoming a political liability for Republicans who remain silent on vaccination. They contend that vaccine positions could alienate voters who otherwise support the party.
Measles outbreaks are turning vaccine policy from a public-health issue into a clear electoral exposure.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A preventable disease outbreak is creating political costs for candidates who avoid taking a clear position on vaccines.
4:30 AMStat News
Opinion: My mother killed herself. I wish assisted suicide had been an option
Summary
In a personal essay, Torie Bosch argues that assisted suicide should be considered for some people with severe mental illness, drawing on her mother's suicide. The essay challenges the assumption that medical aid in dying should be limited to physical illnesses.
Including psychiatric conditions would widen the eligibility debate and force policymakers to define when mental
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The argument tests the boundaries of assisted dying laws and the safeguards built around them.
4:30 AMStat News
STAT+: Does Isomorphic Labs have what it takes to revolutionize drugmaking?
Summary
Isomorphic Labs is trying to turn its technology into a platform for discovering new medicines. Its central challenge is proving that the technology can produce effective drugs, not merely promising computational predictions.
The company is moving from artificial intelligence's promise to the harder test of clinical validation.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
AI will reshape drug development only if it improves outcomes in the costly, failure-prone stages after discovery.
4:00 AMPYMNTS
Why Insured Workers Still Skip Healthcare
Summary
Many insured adults still avoid needed care because medical bills can trigger credit checks or become unaffordable. The article argues that employers track premiums but rarely measure the cost of delayed or forgone treatment.
Insurance has not removed the financial barriers that keep workers from seeking care. Employees face
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Coverage can look adequate on paper while leaving workers unable to use it.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!